✦ LIBER ✦

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

✍ Scribed by E Van Cutsem; D Cunningham; W.W Ten Bokkel Huinink; C.J.A Punt; C.G Alexopoulos; L Dirix; M Symann; G.H Blijham; P Cholet; G Fillet; C Van Groeningen; J.M Vannetzel; F Levi; G Panagos; C Unger; J Wils; C Cote; C Blanc; P Hérait; H Bleiberg

Book ID: 117666047
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 89 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00353-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly irinotecan (CPT-11) in 5-FU heavi

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

✍ M. Benavides; P. García-Alfonso; M. Cobo; A. Muñoz-Martín; S. Gil-Calle; F. Cara 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 88 KB

Activity of continuous-infusion 5-fluoro

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil

✍ Ave Mori, Sergio Bertoglio, Alessandra Guglielmi… 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 200 KB

Pharmacokinetics of Irinotecan (CPT-11)

Pharmacokinetics of Irinotecan (CPT-11) and 5-fluorouracil (5-FU) in a dose finding study in adult patients with solid tumours

✍ Carcas, A.J.; Frías, J.; Hemanz, A.; Díaz Rubio, E.; Cortés-Funes, H.; Sastre, J 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 250 KB

A phase II study of biweekly irinotecan

A phase II study of biweekly irinotecan (CPT-11) and 5-fluorouracil (5-FU) as first line treatment in advanced or metastatic colorectal cancer (CRC)

✍ Salvador, J.; Bernabe, R.; Bolaños, M.; Borrega, P.; Valladares, M.; Cobo, M.; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 371 KB

736 - Consistent safety and efficacy res

736 - Consistent safety and efficacy results in 2 study populations treated with irinotecan (CPT-11) for metastatic colorectal cancer (MCRC) resistant to 5-FU

✍ R. Guimbaud; R. Bugat; E. Van Cutsem; D. Mignard; M. Mahjoubi; P. Canal; C. Blan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 218 KB

770 - Phase I dose finding study of irin

770 - Phase I dose finding study of irinotecan hydrochloride trihydrate (CPT11) with tomudex (TX.) in patients with 5-FU refractory colorectal cancer

✍ D. Cunningham; P. Ross; A. Webb; M. Allen; A. Massey; C. Cote; G. Gruia 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 263 KB